Semaglutide (Wegovy) is an effective medication for weight loss that works by reducing appetite and increasing feelings of fullness, helping to lower calorie intake and promote sustainable weight loss. Studies show that Semaglutide can result in significant weight loss when combined with healthy diet and exercise habits.
At FagerCare, we offer Semaglutide as part of our weight-loss program and provide personalized guidance and expert support to help you achieve the best possible results.
Semaglutide is a medication used to support weight loss and treat type 2 diabetes. It belongs to a class of drugs called GLP-1 analogues, which mimic the body’s natural GLP-1 hormone (glucagon-like peptide-1). Semaglutide works by reducing appetite and increasing feelings of fullness, helping users eat less and reduce calorie intake. The medication also slows gastric emptying and regulates blood sugar levels.
Semaglutide is available under brand names such as Wegovy. The most common side effects are nausea and abdominal discomfort.
BMI is a practical tool to estimate whether your weight is within a healthy range in relation to your height. By using a simple formula (your weight divided by your height squared in meters), BMI can indicate if you are underweight, of normal weight, overweight or obese.
Our medications are recommended for individuals with obesity (a BMI of 30 or higher) or overweight (BMI between 27 and 30) where complications or risk factors exist, such as high blood pressure, elevated cholesterol, high blood sugar, atherosclerosis or sleep apnea.
“I have tried many methods to lose weight, but with FagerCare, I finally saw results. With their advice, I’ve received both support and tools that truly worked for me.”
- Patrik Sturesson
“Semaglutide has truly made a difference for me. I’ve lost weight in a way that feels sustainable and regained both energy and motivation. It feels like a life-changing transformation I can finally hold onto!”
- Tobias Larsson
“I’ve finally started seeing results that feel sustainable and inspiring. I haven’t just lost weight but also feel much more energetic and happier in daily life.”
- Sofia Bäck
Common side effects include nausea, diarrhea, vomiting and constipation, especially at the start of treatment. These symptoms tend to decrease over time as the body adjusts to the medication. Less common side effects may include abdominal pain and gallbladder issues.
Semaglutide is typically given as a subcutaneous injection under the skin once a week. The medication is supplied in a prefilled injection pen and dosing is adjusted according to the doctor’s recommendations.
Semaglutide is approved for treating overweight individuals even without diabetes, provided they have a BMI of 30 (obesity) or higher or a BMI of at least 27 but less than 30 (overweight) with weight-related health conditions.
Copyright © 2024 FagerCare
Produced by Searchminds